Skip to main content
Log in

Can RBC Indices be Used as Screening Test for Beta-Thalassemia in Indian Antenatal Women?

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

To determine the appropriateness of using MCV/MCH as screening test for beta-thalassemia trait in the present population and also to find the most appropriate cutoff for optimum sensitivity of these indices.

Methods

It was an analytical, observational and cross-sectional study. Complete blood count followed by high-performance liquid chromatography (HPLC) was performed. The MCV and MCH levels were noted in cases and controls.

Results

Thalassemia trait was found in 66 out of 1300 antenatal women with anemia. The MCV and MCH were significantly low in cases (p = 0.0001). MCV had a better AUC (0.650) than MCH (0.635). The most suitable cutoff value of MCV was calculated as 72 fl (sensitivity—63.7%, specificity—68.3%, PPV—9.7%, LR—2.0) and that for MCH was 24 pg (sensitivity—63.6%, specificity—59.4%, PPV—7.7%, LR—1.5) using Youden’s index. When MCH (cutoff of 28 pg) and MCV were combined (cutoff of 74 fl), the sensitivity and specificity were 95% and 16%, respectively.

Conclusion

The sensitivity and specificity of MCV and MCH alone had low detection rate when used in combination had high sensitivity but the specificity was low; therefore, HPLC should be the preferred screening test for beta-thalassemia in Indian women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kaur K. Anemia ‘a silent killer’ among women in India: present scenario. Eur J Zool Res. 2014;3(1):32–6.

    Google Scholar 

  2. Madan N, Sharma S, Sood SK, et al. Frequency of beta thalassemia trait and other hemoglobinopathies in Northern and Western India. Indian J Hum Genet. 2010;16:16–25.

    Article  CAS  Google Scholar 

  3. Tamhankar PM, Agarwal S, Arya V, et al. Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India. Prenat Diagn. 2009;29(1):83–8.

    Article  Google Scholar 

  4. Mendiratta SL, Bajaj S, Popli S, et al. Screening of women in the antenatal period for thalassemia carrier status: comparison of NESTROFT, red cell indices, and HPLC analysis. J Fetal Med. 2015;2(I):21–5.

    Article  Google Scholar 

  5. Mohapatra R, Warang P, Ghosh K, et al. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye. Cytom B Clin Cytom. 2016;90(3):279–84.

    Article  CAS  Google Scholar 

  6. Piplani S, Manan R, Lalit M, et al. NESTROFT—a valuable, cost effective screening test for beta thalassemia trait in North Indian Punjabi Population. J Clin Diagn Res. 2013;7(12):2784.

    PubMed  PubMed Central  Google Scholar 

  7. Tunkyi K, Moodley J. Prevalence of anaemia in pregnancy in a regional health facility in South Africa. S Afr Med J. 2015;106(1):101–4.

    Article  CAS  Google Scholar 

  8. Pranpanus S, Sirichotiyakul S, Srisupundit K, et al. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait. J Med Assoc Thai. 2009;92(6):739–43.

    PubMed  Google Scholar 

  9. Batebi A, Pourreza A, Esmailian R. Discrimination of beta-thalassemia minor and iron deficiency anemia by screening test for red blood cell indices. Turk J Med Sci. 2012;42(2):275–80.

    CAS  Google Scholar 

  10. Ghosh K, Colah R, Manglani M, et al. Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet. 2014;20(2):101–19.

    Article  Google Scholar 

  11. Khera R, Singh T, Khuana N, et al. HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation. Indian J Hematol Blood Transfus. 2015;31(1):110–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Mayura Balliyan conducted the study, co-analyzed the data, and drafted and revised the manuscript. Manisha Kumar was involved in the concept and planning of the study, conducted the study, co-analyzed the data and drafted the manuscript. Anita Nangia conducted the study and drafted the manuscript. Nupur Parakh conducted the study and revised the manuscript.

Corresponding author

Correspondence to Manisha Kumar.

Ethics declarations

Conflict of interest

There is no potential conflict of interest among authors.

Human Participants and Informed Consent

The research involved human participants. Informed consent was taken before the study.

Ethical Standard

Ethical clearance was taken before the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Mayura Baliyan is a Resident at Department of Obstetrics and Gynecology, LHMC, New Delhi, India. Manisha Kumar is a Professor (OBGYN) at Department of Obstetrics and Gynecology, LHMC, New Delhi, India. Anita Nangia is a Professor at Department of Pathology, LHMC, New Delhi, India. Nupur Parakh is a Senior Medical Officer at KSCH, New Delhi, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baliyan, M., Kumar, M., Nangia, A. et al. Can RBC Indices be Used as Screening Test for Beta-Thalassemia in Indian Antenatal Women?. J Obstet Gynecol India 69, 495–500 (2019). https://doi.org/10.1007/s13224-019-01220-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-019-01220-8

Keywords

Navigation